Animal model of autism induced by prenatal exposure to valproate: Behavioral changes and liver parameters

Brain Research

Volumn 1408, Issue , 2011, Pages 8-16

  Bambini Junior, Victorio ^a   Rodrigues, Leticia ^a   Behr, Guilherme Antônio ^a   Moreira, José Cláudio Fonseca ^a   Riesgo, Rudimar ^a,b   Gottfried, Carmem ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Animal model; Autism spectrum disorder; Behavioral impairment; Sodium valproate

Indexed keywords

CATALASE; SUPEROXIDE DISMUTASE; VALPROIC ACID;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTISM; BEHAVIOR CHANGE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; INTERPERSONAL COMMUNICATION; LANGUAGE; LIVER FUNCTION; MALE; NEWBORN; NONHUMAN; PLACE PREFERENCE; PLAY; PRENATAL EXPOSURE; PRIORITY JOURNAL; RAT; SOCIAL INTERACTION; STEREOTYPY;

AGING; ALANINE TRANSAMINASE; ANIMALS; ANTICONVULSANTS; ASPARTATE AMINOTRANSFERASES; AUTISTIC DISORDER; BEHAVIOR, ANIMAL; CATALASE; DISEASE MODELS, ANIMAL; FEMALE; LIVER; LIVER FUNCTION TESTS; MAZE LEARNING; OXIDATION-REDUCTION; OXIDATIVE STRESS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROTEIN CARBONYLATION; RATS; RATS, WISTAR; SOCIAL BEHAVIOR; SULFHYDRYL COMPOUNDS; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VALPROIC ACID;

ANIMALIA; RATTUS; RODENTIA;

EID: 80051491682     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.06.015     Document Type: Article

References (50)

1. H. Aebi Catalase in vitro Methods Enzymol. 105 1984 121 126
2. M.A. Aguilar, J. Minarro, and V. Felipo Chronic moderate hyperammonemia impairs active and passive avoidance behavior and conditional discrimination learning in rats Exp. Neurol. 161 2000 704 713 (Pubitemid 30137027)
3. Aires, C.C., Cruchten, A.V., Ijlst, L., de Almeida, I.T., Duran, M., Wanders, R.J., Silva, M.F., in press. New insights on the mechanisms of valproate-induced hyperammonemia: Inhibition of hepatic N-acetylglutamate synthase activity by valproyl-Coa. J. Hepatol. doi:10.1016/j.jhep.2010.11.031.
4. R. Alsdorf, and D.F. Wyszynski Teratogenicity of sodium valproate Expert Opin. Drug Saf. 4 2005 345 353 (Pubitemid 40867344)
5. S.C. Bello Autism and environmental influences: review and commentary Rev Environ. Health 22 2007 139 156 (Pubitemid 47310569)
6. P.E. Binkerd, J.M. Rowland, H. Nau, and A.G. Hendrickx Evaluation of valproic acid (VPA) developmental toxicity and pharmacokinetics in Sprague-Dawley rats Fundam. Appl. Toxicol. 11 1988 485 493 (Pubitemid 18261931)
7. C. Blaiss, J. Blundell, M. Etherton, T.C. Sudhof, and C.M. Powell Autism-relevant animal models with pharmacologically reversible, increased repetitive behaviors Ann. Neurol. 66 2009 S62-S62
8. R.L. Bromley, G. Mawer, J. Clayton-Smith, and G.A. Baker Autism spectrum disorders following in utero exposure to antiepileptic drugs Neurology 71 2008 1923 1924
9. R.L. Bromley, G. Mawer, J. Love, J. Kelly, L. Purdy, L. McEwan, M. Briggs, J. Clayton-Smith, X. Sin, and G.A. Baker Early cognitive development in children born to women with epilepsy: a prospective report Epilepsia 51 2010 2058 2065
10. M.F. Casanova The neuropathology of autism Brain Pathol. 17 2007 422 433 (Pubitemid 47537606)
11. M.G. Chez, and N. Guido-Estrada Immune therapy in autism: historical experience and future directions with immunomodulatory therapy Neurotherapeutics 7 2010 293 301
12. A.L. Christianson, N. Chesler, and J.G. Kromberg Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs Dev. Med. Child Neurol. 36 1994 361 369 (Pubitemid 24088567)
13. S.A. Currenti Understanding and determining the etiology of autism Cell. Mol. Neurobiol. 30 2010 161 171
14. J.L. Delongeas, G.V. de Conchard, A. Beamonte, H. Bertheux, C. Spire, C. Maisonneuve, N. Becourt-Lhote, F. Goldfain-Blanc, and N. Claude Assessment of Labrasol(R)/Labrafil(R)/Transcutol(R) (4/4/2, v/v/v) as a non-clinical vehicle for poorly water-soluble compounds after 4-week oral toxicity study in Wistar rats Regul. Toxicol. Pharmacol. 57 2010 284 290
15. E. DiCicco-Bloom, C. Lord, L. Zwaigenbaum, E. Courchesne, S.R. Dager, C. Schmitz, R.T. Schultz, J. Crawley, and L.J. Young The developmental neurobiology of autism spectrum disorder J. Neurosci. 26 2006 6897 6906 (Pubitemid 44309856)
16. H.H. Draper, and M. Hadley Malondialdehyde determination as index of lipid peroxidation Methods Enzymol. 186 1990 421 431 (Pubitemid 20279983)
17. D. Dufour-Rainfray, P. Vourc'h, A.M. Le Guisquet, L. Garreau, D. Ternant, S. Bodard, E. Jaumain, Z. Gulhan, C. Belzung, C.R. Andres, S. Chalon, and D. Guilloteau Behavior and serotonergic disorders in rats exposed prenatally to valproate: a model for autism Neurosci. Lett. 470 2010 55 59
18. G.L. Ellman Tissue sulfhydryl groups Arch. Biochem. Biophys. 82 1959 70 77
19. E. Fombonne The epidemiology of autism: a review Psychol. Med. 29 1999 769 786 (Pubitemid 29381037)
20. E. Fombonne The prevalence of autism JAMA 289 2003 87 89 (Pubitemid 36026283)
21. E. Fombonne Epidemiology of pervasive developmental disorders Pediatr. Res. 65 2009 591 598
22. C.A. Gadia, R. Tuchman, and N.T. Rotta Autism and pervasive developmental disorders J. Pediatr. (Rio J) 80 2004 S83 S94
23. C. Giulivi, Y.F. Zhang, A. Omanska-Klusek, C. Ross-Inta, S. Wong, I. Hertz-Picciotto, F. Tassone, and I.N. Pessah Mitochondrial dysfunction in autism JAMA 304 2010 2389 2396
24. B. Halliwell Reactive species and antioxidants. Redox biology is a fundamental theme of aerobic life Plant Physiol. 141 2006 312 322 (Pubitemid 43974521)
25. J.L. Ingram, S.M. Peckham, B. Tisdale, and P.M. Rodier Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism Neurotoxicol. Teratol. 22 2000 319 324 (Pubitemid 30326672)
26. H. Jyonouchi, S. Sun, and H. Le Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression J. Neuroimmunol. 120 2001 170 179 (Pubitemid 33016737)
27. L. Kanner Autistic disturbances of affective contact Nerv. Child 1943 217 250
28. M.D. Kogan, S.J. Blumberg, L.A. Schieve, C.A. Boyle, J.M. Perrin, R.M. Ghandour, G.K. Singh, B.B. Strickland, E. Trevathan, and P.C. van Dyck Prevalence of parent-reported diagnosis of autism spectrum disorder among children in the US, 2007 Pediatrics 124 2009 1395 1403
29. E. Kolozsi, R.N. Mackenzie, F.I. Roullet, D. Decatanzaro, and J.A. Foster Prenatal exposure to valproic acid leads to reduced expression of synaptic adhesion molecule neuroligin 3 in mice Neuroscience 163 2009 1201 1210
30. P.J. Landrigan What causes autism? Exploring the environmental contribution Curr. Opin. Pediatr. 22 2010 219 225
31. R.L. Levine, D. Garland, C.N. Oliver, A. Amici, I. Climent, A.G. Lenz, B.W. Ahn, S. Shaltiel, and E.R. Stadtman Determination of carbonyl content in oxidatively modified proteins Methods Enzymol. 186 1990 464 478 (Pubitemid 20279989)
32. F.K. Marcondes, F.J. Bianchi, and A.P. Tanno Determination of the estrous cycle phases of rats: some helpful considerations Braz. J. Biol. 62 2002 609 614
33. K. Markram, T. Rinaldi, D. La Mendola, C. Sandi, and H. Markram Abnormal fear conditioning and amygdala processing in an animal model of autism Neuropsychopharmacology 33 2008 901 912 (Pubitemid 351252688)
34. H.P. Misra, and I. Fridovich The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase J. Biol. Chem. 247 1972 3170 3175
35. R. Muhle, S.V. Trentacoste, and I. Rapin The genetics of autism Pediatrics 113 2004 e472 e486
36. C.L. Murcia, F. Gulden, and K. Herrup A question of balance: a proposal for new mouse models of autism Int. J. Dev. Neurosci. 23 2005 265 275 (Pubitemid 40313558)
37. J.J. Nadler, S.S. Moy, G. Dold, D. Trang, N. Simmons, A. Perez, N.B. Young, R.P. Barbaro, J. Piven, T.R. Magnuson, and J.N. Crawley Automated apparatus for quantitation of social approach behaviors in mice Genes Brain Behav. 3 2004 303 314 (Pubitemid 39277417)
38. C.A. Pardo, D.L. Vargas, and A.W. Zimmerman Immunity, neuroglia and neuroinflammation in autism Int. Rev. Psychiatry 17 2005 485 495 (Pubitemid 43086675)
39. B. Piedrafita, S. Erceg, O. Cauli, P. Monfort, and V. Felipo Developmental exposure to polychlorinated biphenyls PCB153 or PCB126 impairs learning ability in young but not in adult rats Eur. J. Neurosci. 27 2008 177 182
40. I. Rapin, and R.F. Tuchman Autism: definition, neurobiology, screening, diagnosis Pediatr. Clin. North Am. 55 2008 1129 1146 viii
41. P.M. Rodier, J.L. Ingram, B. Tisdale, and V.J. Croog Linking etiologies in humans and animal models: studies of autism Reprod. Toxicol. 11 1997 417 422 (Pubitemid 27180653)
42. F.I. Roullet, L. Wollaston, D. Decatanzaro, and J.A. Foster Behavioral and molecular changes in the mouse in response to prenatal exposure to the anti-epileptic drug valproic acid Neuroscience 170 2010 514 522
43. T. Schneider, and R. Przewlocki Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism Neuropsychopharmacology 30 2005 80 89 (Pubitemid 40024402)
44. T. Schneider, J. Turczak, and R. Przewlocki Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic approach in autism Neuropsychopharmacology 31 2006 36 46 (Pubitemid 43250939)
45. M. South, S. Ozonoff, and W.M. McMahon The relationship between executive functioning, central coherence, and repetitive behaviors in the high-functioning autism spectrum Autism 11 2007 437 451 (Pubitemid 47616528)
46. E. Stokstad Development. New hints into the biological basis of autism Science 294 2001 34 37 (Pubitemid 32952933)
47. N. Tsujino, Y. Nakatani, Y. Seki, A. Nakasato, M. Nakamura, M. Sugawara, and H. Arita Abnormality of circadian rhythm accompanied by an increase in frontal cortex serotonin in animal model of autism Neurosci. Res. 57 2007 289 295 (Pubitemid 46177302)
48. H.B. van der Worp, D.W. Howells, E.S. Sena, M.J. Porritt, S. Rewell, V. O'Collins, and M.R. Macleod Can animal models of disease reliably inform human studies? PLoS Med. 7 2010 e1000245
49. C.V. Vorhees, H.L. Johnson, L.N. Burns, and M.T. Williams Developmental treatment with the dopamine D2/3 agonist quinpirole selectively impairs spatial learning in the Morris water maze Neurotoxicol. Teratol. 31 2009 1 10
50. G.C. Wagner, K.R. Reuhl, M. Cheh, P. McRae, and A.K. Halladay A new neurobehavioral model of autism in mice: pre-and postnatal exposure to sodium valproate J. Autism Dev. Disord. 36 2006 779 793 (Pubitemid 44284982)